The University of Mississippi Medical Center Cancer Center and Research Institute received a $1.4 million grant from the U.S.

Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.

During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...

Sleep apnoea is a sleep disorder that causes a person to repeatedly stop or shallowly breathe while sleeping Read this ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Abiraterone is under clinical development by Austhera BioSciences and currently in Phase II for Hormone-Sensitive Prostate Cancer.

Tevimbra is under clinical development by BeiGene and currently in Phase II for Androgen-Sensitive Prostate Cancer.

INR:4417. buffalo casino slots Prostate cancer hormone therapy may increase risk of Alzheimer's disease, dementia 81% of pediatric patients cleared skin symp ...

INR:5182. pig winner slot machine Review丨Major events in the medical industry in 2020 First of its kind! Antengene Pharmaceuticals submits new anticance ...

flash rummy Prostate cancer hormone therapy may increase risk of Alzheimer's disease, dementia 2019 H1 Financial Report: Novartis and Roche achieved stable growth in the Chinese market Two more ...

INR:8656. ancient egypt timeline [Breaking News] Kelun's first inhaler is here! The 20 billion market is rapidly heating up Prostate cancer hormone therapy ...

peak power plant Prostate cancer hormone therapy may increase risk of Alzheimer's disease, dementia The fourth batch of national drug procurement has officially started! 90 dosage forms have been ...